Author/Creator: Luo, Defang - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Luo, Defang

1. 209 A CTS Team Approach to Modeling Migration and Suppression of CCR2+/CX3CR1+ Myeloid Cells in Glioblastoma. (April 2022)

Authors:: Anderson, Hannah; Takacs, Gregory P.; Kreiger, Christian; Luo, Defang; Rong, Libin; Harrison, Jeffrey K.; Stepien, Tracy
Journal:: Journal of clinical and translational science
Issue:: Volume 6(2022)Supplement 1
Page Start:: 32
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Angiotensin II Regulation of Proliferation, Differentiation, and Engraftment of Hematopoietic Stem Cells. Issue 3 (March 2016)

Authors:: Kim, Seungbum; Zingler, Michael; Harrison, Jeffrey K.; Scott, Edward W.; Cogle, Christopher R.; Luo, Defang; Raizada, Mohan K.
Journal:: Hypertension
Issue:: Volume 67:Issue 3(2016:Mar.)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. IMMU-05. CCR2+ MYELOID-DERIVED SUPPRESSOR CELLS FROM MURINE GLIOMAS ARE SOURCED FROM THE BONE MARROW, SUPPRESS T CELL ACTIVATION, AND MIGRATE TO CCL2. (12th November 2021)

Authors:: Takacs, Gregory; Kreiger, Christian; Luo, Defang; Flores-Toro, Joseph; Deleyrolle, Loic; Rahman, Maryam; Mitchell, Duane; Harrison, Jeffrey
Journal:: Neuro-oncology
Issue:: Volume 23: Supplement 6(2021)
Page Start:: vi92
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. IMMU-05. DISRUPTION OF THE CCR2 CHEMOKINE RECEPTOR PATHWAY OVERCOMES THERAPEUTIC RESISTANCE TO PD-1 BLOCKADE IN MALIGNANT GLIOMA. (11th November 2019)

Authors:: Flores-Toro, Joseph; Luo, Defang; Campbell, James; Charo, Israel; Singh, Rajinder; Schall, Thomas; Datta, Meenal; Jain, Rakesh; Mitchell, Duane; Harrison, Jeffrey
Journal:: Neuro-oncology
Issue:: Volume 21(2019)Supplement 6
Page Start:: vi119
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. IMMU-21. GLIOMA-DERIVED FACTORS RECRUIT AND INDUCE AN IMMUNE SUPPRESSIVE PHENOTYPE IN BONE MARROW-DERIVED CCR2+ MYELOID CELLS. (14th November 2022)

Authors:: Takacs, Gregory; Kreiger, Christian; Luo, Defang; Tian, Guimei; Deleyrolle, Loic; Harrison, Jeffrey
Journal:: Neuro-oncology
Issue:: Volume 24(2022)Supplement 7
Page Start:: vii135
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. IMMU-51. THE COMBINATION OF CCR2 ANTAGONIST AND PD-1 BLOCKADE PROLONGS SURVIVAL IN IMMUNE CHECKPOINT INHIBITOR RESISTANT GLIOMAS. (5th November 2018)

Authors:: Flores-Toro, Joseph; Luo, Defang; Gopinath, Adithya; Campbell, James; Charo, Israel; Singh, Rajinder; Schall, Thomas; Harrison, Jeffrey
Journal:: Neuro-oncology
Issue:: Volume 20(2018)Supplement 6
Page Start:: vi132
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. VEGFR inhibitors upregulate CXCR4 in VEGF receptor-expressing glioblastoma in a TGFβR signaling-dependent manner. Issue 1 (28th April 2015)

Authors:: Pham, Kien; Luo, Defang; Siemann, Dietmar W.; Law, Brian K.; Reynolds, Brent A.; Hothi, Parvinder; Foltz, Gregory; Harrison, Jeffrey K.
Journal:: Cancer letters
Issue:: Volume 360:Issue 1(2015)
Page Start:: 60
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗